Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells

Lithium Modulates Cancer Cell Growth, Apoptosis, Gene Expression and Cytokine Production in HL-60 Promyelocytic Leukaemia Cells and Their Drug-Resistant Sub-clones

(2012) Thabe Matsebatlela et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients

(2012) Branislav Jeremić et al.   Clinical & Translational Oncology

Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinomain vitro

(2012) Ayhan Bilir et al.   Journal of Gynecologic Oncology

Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain

(2011) Nciri Riadh et al.   BIOMETALS

5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells

(2011) Zhao-Hui Xie et al.   BMC CANCER

GSK-3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock

(2011) Kyung Tae Noh et al.   EXPERIMENTAL CELL RESEARCH

Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling

(2011) A Gupta et al.   PHARMACOGENOMICS JOURNAL

Use of Lithium in the Treatment of Bipolar Disorder in Late-Life

(2011) Ramsey D’Souza et al.   Current Psychiatry Reports

Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L

(2010) Hong Zhu et al.   CANCER LETTERS

Ursolic Acid, a Pentacyclin Triterpene, Potentiates TRAIL-induced Apoptosis through p53-independent Up-regulation of Death Receptors

(2010) Sahdeo Prasad et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice

(2010) Sung-E Choi et al.   VASCULAR PHARMACOLOGY

Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents

(2009) T Sánchez-Pérez et al.   CELL DEATH AND DIFFERENTIATION

JNK inhibitor SP600125 promotes the formation of polymerized tubulin, leading to G2/M phase arrest, endoreduplication, and delayed apoptosis

(2009) Dong-Oh Moon et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells

(2008) Eléonore Beurel et al.   BIOCHEMICAL PHARMACOLOGY

TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them

(2008) A THORBURN et al.   DRUG RESISTANCE UPDATES

Involvement of the role of Chk1 in lithium‐induced G2/M phase cell cycle arrest in hepatocellular carcinoma cells

(2008) Xiao‐Ming Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: Mechanisms for aquaporin 2 down-regulation and cellular proliferation

(2008) J. Nielsen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3  Inactivation

(2008) T. M. Thornton et al.   SCIENCE

Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest

(2008) Jin-Sheng Wang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Desferrioxamine (DFX) induces apoptosis through the p38-caspase8-Bid-Bax pathway in PHA-stimulated human lymphocytes

(2007) Byeong-Mo Kim et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY